What Is Aggregate Reporting? Types, Deadlines, and Penalties

Aggregate reporting is the practice of rolling up many individual events, such as transactions, adverse drug reactions, or patient records, into a single periodic summary that a regulator uses to detect patterns rather than isolated incidents. Federal rules require it across banking, cash-intensive businesses, pharmaceuticals, and healthcare, and the penalties for missing a filing or getting one wrong can run into six or seven figures per violation.

The point of grouping data this way is trend detection. One suspicious wire transfer, one side effect, or one patient chart tells a regulator almost nothing on its own. Fifty of them over a quarter, sorted by category and compared against a baseline, tell the regulator whether fraud is spreading, whether a drug’s risk profile has shifted, or whether a compliance program is failing.

How Aggregate Reporting Differs From Single-Event Filings

An individual report describes one event: a single wire, one adverse reaction, a particular chart. An aggregate report examines every such event within a defined window (quarterly, annually, or on a custom schedule) and answers different questions. How often. How severe. Getting worse or better.

Preparing one usually means stripping personal identifiers and replacing them with statistical summaries: counts by category, frequency distributions, demographic breakdowns. That protects the individuals inside the data while letting the agency analyze systemic risk. The trade-off is that you cannot summarize what you never captured, so the reporting obligation is really a record-keeping obligation first.

Where Federal Law Requires Aggregate Reporting

Suspicious Activity Reports Under the Bank Secrecy Act

Banks and credit unions must file a Suspicious Activity Report (SAR) when a transaction or a pattern of transactions involves at least $5,000 and the institution suspects the activity is designed to evade Bank Secrecy Act requirements, involves illegal funds, or lacks a lawful purpose.1FinCEN. Suspicious Activity Reporting (Structuring) The aggregation piece matters because a single $3,000 transfer looks routine, while five $3,000 transfers to related accounts inside a week cross the $5,000 line and require a filing. The SAR is due no later than 30 calendar days after the institution first detects the suspicious pattern, extended to 60 days if no suspect has been identified.2FinCEN. FinCEN SAR Electronic Filing Instructions

Currency Transaction Reports

Every financial institution other than a casino must file a Currency Transaction Report (CTR) for each currency transaction that exceeds $10,000.3eCFR. 31 CFR 1010.311 – Filing Obligations for Reports of Transactions in Currency Aggregation applies here as well: if the same customer conducts multiple cash transactions at the same institution on the same day and the combined total tops $10,000, the institution files a CTR even though no single transaction crossed the threshold on its own.

Cash Reporting for Non-Financial Businesses

Aggregate cash reporting reaches beyond banks. Any person or business that receives more than $10,000 in cash, either in one transaction or in related transactions, must file IRS Form 8300 within 15 days. “Related transactions” is the aggregate trigger. A car dealer who takes three separate $4,000 cash payments from the same buyer toward one vehicle has received $12,000 in related transactions and has to file. The business must also send a written statement to each person named on the Form 8300 by January 31 of the following year.4Internal Revenue Service. Form 8300 and Reporting Cash Payments of Over $10,000

Investigational Drug Safety Reports

Sponsors of Investigational New Drug (IND) applications must submit an annual report within 60 days of the IND’s anniversary date. It summarizes the most frequent and most serious adverse experiences by body system, lists all deaths and dropouts tied to adverse events, and includes a summary of every IND safety report filed during the year.5eCFR. 21 CFR 312.33 – Annual Reports Sponsors also file individual safety reports within 15 calendar days when a serious and unexpected adverse reaction is identified. Aggregate analysis is not just a reporting format here; it is itself a trigger. If pooled trial data shows an event occurring more often in the drug arm than in the control arm, that finding requires a safety report.6eCFR. 21 CFR 312.32 – IND Safety Reporting

Postmarketing Reports for Approved Drugs and Biologics

Once a drug is approved, the manufacturer files periodic adverse drug experience reports quarterly for the first three years, then annually. Quarterly reports are due within 30 days of the quarter’s close, and annual reports within 60 days of the approval anniversary.7eCFR. 21 CFR 314.80 – Postmarketing Reporting of Adverse Drug Experiences The FDA can extend or reinstate quarterly reporting, for example after a major supplemental approval that changes the drug’s risk profile. Biologics follow the same quarterly-then-annual schedule under a parallel regulation.8eCFR. 21 CFR 600.80 – Postmarketing Reporting of Adverse Experiences

HIPAA Data Aggregation

The HIPAA Privacy Rule defines “data aggregation” as combining protected health information from multiple covered entities through a business associate so that pooled analyses can support each entity’s healthcare operations.9eCFR. 45 CFR Part 164 – Security and Privacy When aggregate reports are shared more widely, HIPAA requires de-identification, which means removing 18 categories of identifiers (names, small-area geography, dates tied to individuals, contact information, government and medical record numbers, biometrics, and others) so no individual can reasonably be identified. As an alternative, a covered entity can retain a qualified statistician to certify under the expert determination method that the re-identification risk is very small.10eCFR. 45 CFR 164.514 – Other Requirements Relating to Uses and Disclosures of Protected Health Information

Key Deadlines Side by Side

What Non-Compliance Costs

Bank Secrecy Act Violations

A financial institution or individual who willfully violates BSA reporting requirements faces a civil penalty of up to the greater of the transaction amount (capped at $100,000) or $25,000 per violation under the statute.11Office of the Law Revision Counsel. 31 USC 5321 – Civil Penalties After inflation adjustments, the current range for willful violations under this provision runs from $71,545 to $286,184 per violation.12Federal Register. Financial Crimes Enforcement Network Inflation Adjustment of Civil Monetary Penalties A separate violation accrues for each day the failure continues and at each branch where it occurs, so one compliance breakdown across multiple locations can multiply quickly.

Form 8300 Penalties

For negligent failure to file Form 8300 or to include correct information, the IRS imposes $310 per return, up to $3,783,000 per calendar year (figures for returns due in 2024, adjusted annually). Correcting the error within 30 days of the due date drops the per-return penalty to $60. Intentional disregard carries the greater of $31,520 or the amount of cash involved in the transaction, up to $126,000 per return, with no annual cap.13Internal Revenue Service. IRS Form 8300 Reference Guide

FDA Safety Reporting

Companies that fail to submit required clinical trial information face an inflation-adjusted penalty of up to $15,107 per proceeding. For device-related violations, the aggregate of all penalties in a single proceeding can reach $2,364,503.14Federal Register. Annual Civil Monetary Penalties Inflation Adjustment

HIPAA Violations

HIPAA penalties run in four tiers based on culpability. At the “did not know” tier, penalties range from $145 to $73,011 per violation. Violations attributed to reasonable cause but not willful neglect run from $1,461 to $73,011. Willful neglect corrected within 30 days runs from $14,602 to $73,011. Willful neglect that is not corrected runs from $73,011 to $2,190,294 per violation. Each tier carries a calendar-year cap of $2,190,294 for repeat violations of the same requirement.14Federal Register. Annual Civil Monetary Penalties Inflation Adjustment The statutory framework sits in 42 U.S.C. ยง 1320d-5.15Office of the Law Revision Counsel. 42 USC 1320d-5 – General Penalty for Failure to Comply With Requirements and Standards Outside the willful-neglect tiers, a penalty may be waived if the violation is corrected within 30 days of discovery.

How to File

Financial institutions submit SARs, CTRs, and other BSA forms through the BSA E-Filing System, which supports both individual filings and batch uploads over a secure network.16Financial Crimes Enforcement Network. BSA E-Filing System A designated supervisory user enrolls the institution first, then manages credentials for the rest of the team.17Financial Crimes Enforcement Network. Becoming a Registered E-Filer The system returns a confirmation receipt with a tracking number on successful submission.

Pharmaceutical and clinical safety filings go to the FDA through the Electronic Submissions Gateway Next Generation (ESG NextGen), which serves as the single entry point for routing regulatory documents to the appropriate FDA center.18U.S. Food and Drug Administration. Electronic Submissions Gateway Next Generation (ESG NextGen) Individual case safety reports must be submitted in XML format through the gateway.19U.S. Food and Drug Administration. FDA Adverse Event Reporting System (FAERS) Electronic Submissions

Keep the Underlying Records

Filing is only half the obligation. Regulators can request the source data behind any aggregate figure, so retention rules track alongside the filing rules.

If your quarterly summary reports 47 adverse events, you need to be able to produce the 47 underlying records on request. The aggregate number is only as defensible as the raw data behind it.